Glucose-lowering therapy does not slow progression in young people with type 2 diabetes

Treatment with glucose-lowering therapy does not maintain or improve pancreatic beta-cell function in young people recently diagnosed with impaired glucose tolerance or type 2 diabetes mellitus, a study has shown.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research